Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Zeta Global
ZETA
$7.18B
| $4.81M | 0.02% |
354,646
+275,528
| +348% | +$4.92M |
|
802
Trinity Industries
TRN
$2.36B
| $4.81M | 0.02% |
171,292
+45,839
| +37% | +$1.54M |
|
803
PUT
Signet Jewelers
SIG
$3.24B
| $4.8M | 0.02% |
82,700
+78,200
| +1,738% | +$4.48M |
|
|
804
iShares Core S&P 500 ETF
IVV
$892B
| $4.79M | 0.02% |
8,527
-252,989
| -97% | -$149M |
|
805
Hilltop Holdings
HTH
$2.23B
| $4.78M | 0.02% |
156,923
+19,642
| +14% | +$597K |
|
806
Insight Enterprises
NSIT
$4.27B
| $4.78M | 0.02% |
31,845
-29,291
| -48% | -$4.71M |
|
807
State Street SPDR S&P Insurance ETF
KIE
$712M
| $4.77M | 0.02% |
78,831
+17,503
| +29% | +$1.02M |
|
808
Axsome Therapeutics
AXSM
$10.8B
| $4.77M | 0.02% |
+40,866
| New | +$4.66M |
|
809
PUT
GitLab
GTLB
$7.08B
| $4.77M | 0.02% |
+101,400
| New | +$6.2M |
|
810
Rivian
RIVN
$24.3B
| $4.76M | 0.02% |
382,324
-446,214
| -54% | -$5.62M |
|
811
CALL
Blackrock
BLK
$181B
| $4.73M | 0.02% |
5,000
| – | – |
|
812
CALL
American Tower
AMT
$83B
| $4.72M | 0.02% |
21,700
+14,400
| +197% | +$2.82M |
|
813
Janux Therapeutics
JANX
$1.15B
| $4.71M | 0.02% |
+174,350
| New | +$6.57M |
|
814
CALL
Astera Labs
ALAB
$48.2B
| $4.68M | 0.02% |
78,500
+48,800
| +164% | +$4.51M |
|
815
Visa
V
$711B
| $4.68M | 0.02% |
+13,342
| New | +$4.51M |
|
816
Gilead Sciences
GILD
$182B
| $4.68M | 0.02% |
41,729
-120,644
| -74% | -$12.4M |
|
817
PUT
Lamb Weston
LW
$7.58B
| $4.67M | 0.02% |
87,600
+53,800
| +159% | +$3.05M |
|
818
EverQuote
EVER
$943M
| $4.66M | 0.02% |
+177,867
| New | +$4.07M |
|
819
Huron Consulting
HURN
$2.59B
| $4.6M | 0.02% |
32,095
+27,884
| +662% | +$3.75M |
|
|
OLO
820
DELISTED
Olo Inc
OLO
| $4.58M | 0.02% |
758,332
+284,226
| +60% | +$1.98M |
|
821
EXL Service
EXLS
$5.72B
| $4.58M | 0.02% |
+96,986
| New | +$4.67M |
|
822
PUT
Ralph Lauren
RL
$22.1B
| $4.57M | 0.02% |
+20,700
| New | +$5.13M |
|
823
Perimeter Solutions
PRM
$5.06B
| $4.57M | 0.02% |
453,373
-260,877
| -37% | -$2.93M |
|
824
PUT
Wells Fargo
WFC
$257B
| $4.56M | 0.02% |
63,500
-1,400
| -2% | -$105K |
|
825
Cognizant
CTSH
$28B
| $4.55M | 0.02% |
+59,523
| New | +$4.85M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.